The Ames test, developed by Bruce N. Ames, uses modified Salmonella bacteria to detect chemical mutagens that may also be carcinogens. This assay has been influential in genetic toxicology since the 1970s and involves exposing bacteria to various chemicals to observe mutations. Over the years, the test has been refined to improve sensitivity and remains a popular method for assessing mutagenicity.
-
The Ames Salmonella / Microsome Mutagenicity Assay #
, 8 highlightsHowever, when a mutagen is added to the plate, the number of revertant colonies per plate is increased, usually in a dose-related manner.
leave the bacteria unable to synthesize the required amino acid, histidine, and therefore unable to grow and form colonies in its absence
The Salmonella strains used in the test have different mutations in various genes in the histidine operon; each of these mutations is designed to be responsive to mutagens that act via different mechanisms.
(base-pair substitution mutants),
(frameshift mutants)
When the histidine dependent bacteria are grown Fig. 1. Spot test with strain TA100 and methyl methanesulfonate (10 l). on a glucose minimal (GM) agar plate containing a trace amount of histidine, only those cells that revert to histidine independence (His+) are able to form colonies. The small amount of histidine allows all the plated bacteria to undergo a few cell divisions; in many cases, this growth is essential for mutagenesis to occur. The His+ revertants are easily scored as colonies against the slight background growth. The number of spontaneously induced revertant colonies is relatively constant for each strain. However, when a mutagen is added to the plate, the number of revertant colonies per plate is increased, usually in a dose related manner as depicted in Fig. 3.
the cytochrome-based P450 metabolic oxidation system,
The addition of a small amount of histidine to the top agar allows all the plated bacteria (approximately 1×108 cells) to undergo between six and eight cell di- vision before the histidine is depleted. In many cases, this limited growth is essential for mutagenesis to oc- cur by allowing fixation of the mutational lesions
-
Ch 9 - Epidemiology | Core Psychiatry #
, 4 highlightsThe basic strategy is to com- pare the distribution of disease between groups or between populations, looking for associations between hypothesized risk factors (genes, behaviours, lifestyles, environmental expo- sures) and health states.
Recall bias occurs when participants in a study are systemati- cally more or less likely to recall and relate information on exposure depending on their outcome status, or to recall infor- mation regarding their outcome dependent on their exposure.
Information bias can be reduced in case–control studies by keeping participants and observers blind to the hypotheses un- der investigation. This can be difficult, and some would argue may challenge the ethical principal of informed consent. How- ever, biased research results are wrong, misleading and a waste of subjects’ time. Blinding can be encouraged by making the title of the study non-specific, and by including irrelevant questions in the risk factor questionnaire to distract subjects from the cen- tral hypothesis under investigation.
Case–control ... studies aim to recruit, from a notional base population, a ran- dom sample of all persons with the disease under study (cases) and a random sample of persons without the disease (controls). The odds of being exposed for cases is compared with the odds of being exposed for controls.
-
Drones will realize the promise of suicide terrorism #
, 4 highlightsAmerica’s defense apparatus (and, by extension, the “liberal world order” itself) is built around standoff capability.
Eventually terror bombings in the West became geopolitically irrelevant. (They still happen, but they don’t motivate policy, except to drive radicalization against immigrants in Europe.)
The new technology fundamentally altered the returns to scale in defense.
We can credibly control nukes because enriched nuclear material has few deniable civilian applications.
But drone technology is too cheap, too modular, and with too many useful civilian applications for the big players to control their manufacture.
-
The Ames Test and the Real World #
, 3 highlightsAmes's point is that the mental division many people have between "artificial" or "synthetic" chemicals (bad) and "natural" ones (good) is nonsense.
Ames has forcefully made the point that testing compounds in animals at or near their maximum tolerated dose (MTD) is a poor measure of their cancer-causing potential. About half the compounds so tested show up as carcinogens, but the dose-response curves aren't linear.
MED, the minimum efficacious dose
-
Bruce Ames, 95, Dies; Biochemist Discovered Test for Toxic Chemicals #
, 2 highlightsThe test was widely used in part because Dr. Ames did not patent his discovery, a decision almost “unheard-of” in biomedical research, said Randy Schekman, a Nobel laureate at Berkeley. Dr. Ames shipped out his mutant bacteria to governments, universities and businesses, asking only that private companies make small donations to help pay for his lab’s labor and the cost of delivery.
He felt that some activists were overstating the risks of these chemicals and targeting chemical companies unfairly. He often said that he thought there was too much focus on substances that were technically mutagenic but that were no more likely to cause DNA damage than the “natural” chemicals found in fruits and vegetables.
-
Can ‘progress studies’ contribute to knowledge? History suggests caution #
, 1 highlightWe should be wary about Collison and Cowen’s advice to study the “successful” and train the “brilliant” in order to speed up “progress.” Neither recent nor more distant history suggests that these terms have neutral definitions. To the contrary, they have often been excuses for colonial expropriation and social exclusion, and sometimes alibis for democratic and environmental catastrophe.
-
The most-feared assays #
, 1 highlightUsing a panel of mutated bacteria that have trouble repairing damage to their DNA, the Ames test looks to see if your compound is causing any. A positive Ames isn’t all that common, but it will cast an immediate shadow over a drug candidate in most organisations.